Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Ascent Resources ask shareholders for ability to raise funds


Advanced Onco Share Price (AVO)



Share Price Information for Advanced Onco (AVO)


Share Price: 43.00Bid: 42.00Ask: 44.00Change: 0.00 (0.00%)No Movement on Advanced Onco
Spread: 2.00Spread as %: 4.76%Open: 45.00High: 45.00Low: 43.00Yesterday’s Close: 43.00

Advanced Oncotherapy Plc Ord 25P

Advanced Onco is listed in the FTSE AIM All-Share
Advanced Onco is part of the Health Care and Related Services sector

Advanced Onco is part of the Real Estate Investment & Services sector





Share Price SpacerPrice
43.00
Share Price SpacerBid
42.00
Share Price SpacerAsk
44.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
209,734
Share Price SpacerOpen
45.00
Share Price SpacerHigh
45.00
Share Price SpacerLow
43.00
Share Price SpacerClose
43.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 169.57m £72.91m 4,000

52 Week High 63.50 52 Week High Date 27-APR-2018
52 Week Low 26.00 52 Week Low Date 28-NOV-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
19 121,005 88,729 -2.450 -17.55 0.00 0.00


London South East Users info for Advanced Onco




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

14-Nov-18
16:51:31
44.00
20,000
Buy* 
42.00
44.00
8,800
Trade Type:
Ordinary

14-Nov-18
16:37:22
39.00
65,000
Sell* 
42.00
44.00
25.35k
Trade Type:
Ordinary

14-Nov-18
16:19:12
42.00
10,000
Sell* 
42.00
44.00
4,200
Trade Type:
Ordinary




View more Advanced Onco trades >>

Directors Deals for Advanced Onco (AVO)
Trade DateActionNotifierPriceCurrencyAmountHolding
02-Aug-18Placing
Trade Notifier Information for Advanced Oncotherapy
Nick Plowman held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Nick Plowman
49GBX306,1224084354
02-Aug-18Placing
Trade Notifier Information for Advanced Oncotherapy
Enrico Cipro Vanni held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Enrico Cipro Vanni
49GBX204,0821926361
02-Aug-18Placing
Trade Notifier Information for Advanced Oncotherapy
Hans von Celsing held the position of Non-Executive Director at Advanced Oncotherapy at the time of this trade.
 Hans von Celsing
49GBX30,00030000
View more Advanced Onco directors dealings >>


solow
Posts: 2
Opinion:No Opinion
Price:45.00
RE: Query
Tue 19:50
Actually the system doesn't know whether a trade is a buy or a sell. It simply decides based on the price. If the trade price is below the mid-price, the system identifies the trade as a sell and vice versa. When the trade price is exactly mid way, the system can't tell. In fact, I have put through trades where the system has incorrectly marked as a buy or sell because my broker has gotten me either a good buy price below the mid or vice versa. So not all trades are market correctly. Hope that helps!
Birch86
Posts: 2
Opinion:No Opinion
Price:45.00
RE: Query
Tue 18:27
Thanks max19
max19
Posts: 2,929
Opinion:No Opinion
Price:45.00
RE: Query
Tue 17:48
When the spread (the difference between the bid price and the ask one) is fairly big the system can't always identified between buying and selling transactions...hence the black reporting.
Birch86
Posts: 2
Opinion:No Opinion
Price:45.00
Query
Tue 17:42
Why do some of the trades go through in black text?, (blue for buy, red for sell)
View more share chat for Advanced Onco (AVO) >>




Website: Advanced Oncotherapy Plc Ord 25P
Website Description: www.advancedoncotherapy.com



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.